新型集成可穿戴人工肺的体外与体内评估
本研究开发了用于肺衰竭患者桥接移植或恢复期可行走的匹兹堡移动辅助肺(PAAL),并进行了体外和急性体内测试。PAAL集成离心泵和0.65 m2中空纤维膜,在4只40-60 kg绵羊体内测试6小时,结果达到体外和急性体内性能目标。
要点
- PAAL在3.5 L/min血流下体外氧合达180 ml/min,气交换效率278 ml/min/m2。
- 体内6小时测试中血液100%氧合,3.8 L/min血流下氧合达181 ml/min。
- 溶血指数为0.054 g/100 L,所有动物血浆游离血红蛋白<20 mg/dl。
核心结论
- PAAL达到了体外和急性体内性能目标。
- 计划近期开展为期5天的慢性绵羊研究。
研究设计与样本
- 研究对PAAL进行体外流体力学、气体交换和溶血测试,并在4只40-60 kg成年绵羊体内测试6小时。
- PAAL特征为直径1.75英寸的圆柱形中空纤维膜束,表面积0.65 m2,集成离心泵。
- 动物通过右颈外静脉置入Avalon Elite 27Fr双腔导管至SVC、RA和IVC。
主要发现
- PAAL在2100 rpm下3.5 L/min流量时泵压>250 mm Hg。
- 体外氧合性能达到3.5 L/min血流下180 ml/min的目标,气交换效率为278 ml/min/m2。
- PAAL和插管的归一化溶血指数(NIH)为0.054 g/100 L(n=2),对照组为0.020 g/100 L(n=2)。
- 所有动物血浆游离血红蛋白(pfHb)<20 mg/dl。
- 体内血液离开装置时100%氧合,3.8 L/min血流下氧合达181 ml/min。
临床怎么用
- PAAL设计允许肺衰竭患者在桥接移植或恢复期间行走。
- 急性动物实验显示其气体交换和溶血性能符合预期,但需进一步慢性研究验证。
局限性
- 仅进行了6小时急性动物实验,样本量小(n=4)。
- 慢性5天研究尚未进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional extracorporeal membrane oxygenation (ECMO) is cumbersome and is associated with high morbidity and mortality. We are currently developing the Pittsburgh Ambulatory Assist Lung (PAAL), which is designed to allow for ambulation of lung failure patients during bridge to transplant or recovery. In this study, we investigated the in vitro and acute in vivo performance of the PAAL. METHODS: The PAAL features a 1.75-inch-diameter, cylindrical, hollow-fiber membrane (HFM) bundle of stacked sheets, with a surface area of 0.65 m2 integrated with a centrifugal pump. The PAAL was tested on the bench for hydrodynamic performance, gas exchange and hemolysis. It was then tested in 40- to 60-kg adult sheep (n = 4) for 6 hours. The animals were cannulated with an Avalon Elite 27Fr dual-lumen catheter (DLC) inserted through the right external jugular into the superior vena cava (SVC), right atrium (RA) and inferior vena cava (IVC). RESULTS: The PAAL pumped >250 mm Hg at 3.5 liters/min at a rotation speed of 2,100 rpm. Oxygenation performance met the target of 180 ml/min at 3.5 liters/min of blood flow in vitro, resulting in a gas-exchange efficiency of 278 ml/min/m2. The normalized index of hemolysis (NIH) for the PAAL and cannula was 0.054 g per 100 liters (n = 2) at 3.5 liters/min, as compared with 0.020 g per 100 liters (n = 2) for controls (DLC cannula and a Centrimag pump). Plasma-free hemoglobin (pfHb) was <20 mg/dl for all animals. Blood left the device 100% oxygenated in vivo and oxygenation reached 181 ml/min at 3.8 liters/min. CONCLUSION: The PAAL met in vitro and acute in vivo performance targets. Five-day chronic sheep studies are planned for the near future.
引用
- Madhani SP, Frankowski BJ, Burgreen GW, et al. In vitro and in vivo evaluation of a novel integrated wearable artificial lung. J Heart Lung Transplant. 2017. PMID: 28359655. doi:10.1016/j.healun.2017.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。